Latest News in the pharma Industry

Top Stories

Asymchem Laboratories Announces Introduction of New Manufacturing Facility

Asymchem Laboratories Announces Introduction of New Manufacturing Facility

16 Feb 2012

The facility was built to meet an annual demand for commercial projects > 5 MT and will serve to expand Asymchem's capabilities in high volume processing and back-end ingredient and intermediate production.

Read more 
Biogen Idec to Acquire Stromedix

Biogen Idec to Acquire Stromedix

15 Feb 2012

Biogen Idec will make an upfront cash payment of $75 million and additional contingent value payments of up to $487.5 million based on the achievement of certain development and approval milestones across multiple indications.

Read more 
Ockham Completes Acquisition of Nexus Oncology

Ockham Completes Acquisition of Nexus Oncology

15 Feb 2012

This merger offers an enhanced global scale, a depth of oncology-specific therapeutic expertise and new levels of operational excellence.

Read more 
BMS Completes Acquisition of Inhibitex

BMS Completes Acquisition of Inhibitex

14 Feb 2012

Bristol-Myers Squibb has announced the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc.

Read more 
Particle Sciences Collaborates with Chemo

Particle Sciences Collaborates with Chemo

14 Feb 2012

Under the agreement, the two companies will leverage each other’s strengths to provide a start to finish contract solution for those looking to develop and market hormone eluting devices.

Read more 
Bosch Packaging Technology to Acquire Eisai's Machinery Business

Bosch Packaging Technology to Acquire Eisai's Machinery Business

14 Feb 2012

Bosch Packaging Technology is to acquire Eisai’s machinery business to strengthen its position in the pharmaceutical market.

Read more 
Elan Reports Fourth Quarter and Full-Year 2011 Results

Elan Reports Fourth Quarter and Full-Year 2011 Results

10 Feb 2012

Total revenue for the full-year 2011 increased by 19% to $1,068.1 million, from $895.6 million for the full-year 2010.

Read more 
Bend Research Licenses Spray-dried Dispersion Tech to Lilly

Bend Research Licenses Spray-dried Dispersion Tech to Lilly

10 Feb 2012

This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development.

Read more 
Promega develops new assay to test cytotoxicity levels

Promega develops new assay to test cytotoxicity levels

10 Feb 2012

Promega Corporation says its new assay is more flexible than alternatives.

Read more 
PAREXEL Expands Global Clinical Logistics Services

PAREXEL Expands Global Clinical Logistics Services

9 Feb 2012

The new facilities expand on the company’s existing clinical logistics infrastructure throughout North America, Latin America, Europe, Africa and the Asia/Pacific region.

Read more 
Illumina Rejects Roche's Unsolicited Tender Offer

Illumina Rejects Roche's Unsolicited Tender Offer

8 Feb 2012

Illumina's Board of Directors determined that the $44.50 per share cash offer is grossly inadequate in multiple respects, dramatically undervalues Illumina and is contrary to the best interests of Illumina's stockholders.

Read more 
GlaxoSmithKline Reports Full Year Results 2011

GlaxoSmithKline Reports Full Year Results 2011

8 Feb 2012

The underlying pharmaceuticals growth came from new products, partly offset by generic competition to older products in the US and Europe and the increased impact of European austerity measures.

Read more